The role of cystatin c in the prediction of outcome in hypertensive disorders of pregnancy

Cimona Lyn Saldanha, Shabnum Ara, Tabassum Parvez


Background: Hypertensive disorders of pregnancy greatly influence the maternal and foetal outcome in terms of morbidity and mortality. Complications include involvement of the kidney and progression of the disease which leads to deterioration of renal parameters and function. If left unattended, oliguria and renal shutdown are serious sequelae. Hence the importance of monitoring serum concentrations of cystatin C, creatinine and uric acid. The present study was designed to understand the variations of these markers in pregnant women in this part of India.

Methods: Serum levels were therefore determined in samples from 75 healthy women at term as well as in 38 samples of patients with Gestational hypertension and in 30 patients with pre-eclampsia (PE). The values were analysed after tabulation and results subjected to statistical analysis using SPSS software programme.

Results: The levels of all three components were significantly higher in pre-eclamptic patients when compared to healthy controls with the mean±SD being 1.86±0.82 vs. 1.08±0.33 for cystatin C, 0.93±0.18 vs. 0.62±0.07 for creatinine and 7.02±1.92 vs. 4.04±1.06 for uric acid respectively. In gestational hypertension, cystatin C was significantly higher, 1.42±1.1 unlike creatinine, 0.84±0.16 and uric acid, 5.26±1.40.

Conclusions: In view of significant increase in serum cystatin C, creatinine and uric acid in hypertensive disorders of pregnancy compared to those of healthy pregnant women, in our study, we conclude that these parameters are of significant value if used as markers to predict the onset of GH/PE. This can be established after further and larger clinical trials.


Cystatin C, Creatinine, Gestational hypertension, Pre-eclampsia, Renal Markers, Uric acid

Full Text:



Kingdom JCP, Jauniaux ERM, Shaughn O'Brien PM. The Placenta: Basic Science and Clinical Practice. Vol.1. London: RCOG-Press; 2000.

Misra al Pregnancy with chronic kidney disease: outcome in Indian women. J Womens Health (Larchmt). 2003;12(10):1019-25.

Salma M, Omar FE. Evaluation of serum cystatin C compared with creatinine: a study in patients with pre-eclampsia. Int J Pharmacol Res. 2015;5(11):273-5.

Padma Y, Aparna VB, Kalpana B, Ritika V, Sudhakar PR. Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study Int J Reprod Contracept Obstet Gynecol. 2013;2(4):514-20.

Murty MSN, Sharma UK, Pandey VB, Kankare SB. Serum cystatin C as a marker of renal function in detection of early acute kidney injury.Indian J Nephrol. 2013;23(3):180-3.

Brown MA, Lindheimer MD, de Sweit M, VanAssche A, Mountquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP. Hypertens pregnancy. 2001;20(1):IX-XIV.

Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:s1-s22.

Strevens H, Wide-swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001;61:575-80.

Strevens D, Wide-swensson H, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG: an international journal of Obstetrics and Gynaecology. 2003;110:825-30.

Franceschini N, Qiu C, Barrow DA, Williams MA. Cystatin C and Preeclampsia: A Case Control Study. Renal Failure. 2008;30:89-95.

Thilaganathan B, Ralph E, Papageorghiou Aris T, Melchiorre K, Sheldon J. Raised maternal cystatin C: An early pregnancy marker for pre-eclampsia. Reproductive sciences. 2009;16(8).

Novakov MA, Cabarkapa V, Nikolic A, Maric D, Brkic S, Mitic G, et al. Cystatin C in pre-eclampsia. J Matern Fetal Neonatal Med. 2012;25(7):961-5.

Babay Z, Al-Wakeel J, Addar M, Mittwalli A, Tarif N, Hammad D, et al. Serum cystatin C in pregnant women: reference values, reliable and superior diagnostic accuracy. Clin Exp Obstet Gynecol. 2005;32(3):175-9.

Fang G, Zhou C, Zhang H. The significance of cystatin C measurement in patients with preeclampsia-eclampsia. Progress in Obstetrics and Gynecology; 2005:03.

Kristensen K, Wide-swensson D, Schmidt C, Blirup-jensen S, Lindstrom V, Strevens H, et al. Cystatin C, β2 microglobulin and β-trace protein in pre-eclampsia. Acta Obstetricia et Gynecologica. 2007;86:921-6.

Singh A. Cystatin C is a better marker of renal dysfunction in hypertensive pregnancies. Ind J Med Bio. 2016;20(1):21-7.

Dhupper V. Evaluation of cystatin C as a marker of estimated glomerular filtration rate in different stages of chronic kidney disease. Sch Acad J Bio sci. 2015;3(4)328-34.

Novakov MA. Cystatin C in pre-eclampsia. J Matern Fetal Neonatal Med. 2012;25(7):961-65.

Sharma S, Ranjan RK, Gupta M, Singh A, Gupta R, Pant L, et al. serum cystatin C with conventional renal tests: a study in patients with pre-eclampsia. Ann Pathol Lab Med. 2014;192:A6-9.